Pyxis Oncology
PYXS
PYXS
47 hedge funds and large institutions have $41.5M invested in Pyxis Oncology in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 8 closing their positions.
Holders
47
Holders Change
+16
Holders Change %
+51.61%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
8
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ACP
51
Acuta Capital Partners
Redwood City,
California
| – | – | -669,158 | Closed |
|
52
Citigroup
New York
| – | – | -357,537 | Closed |
|
|
MAM
53
Marquette Asset Management
Minneapolis,
Minnesota
| – | – | -58,862 | Closed |
|
54
Two Sigma Investments
New York
| – | – | -35,477 | Closed |
|
55
Millennium Management
New York
| – | – | -31,334 | Closed |
|
|
CFGS
56
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|